Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Pharmaxis.
RELATED STOCKHEAD STORIES
News
Trading Places: Alex Waislitz’s Thorney Opportunities chipped in to these ASX stocks
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Investors could be in the eye of a storm
Health & Biotech
Pharmaxis to get $14m payday after its cystic fibrosis treatment Bronchitol approved by FDA
News
10 at 10: These ASX stocks are ascending from the horizon this morning
Experts
ScoPo’s health powerplays: Pot stocks get a boost
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Have markets stabilised after that ‘quick and severe’ correction?
Health & Biotech
Pharmaxis dealt another blow as partner backs out of second drug development
News
10 at 10: These ASX stocks are leading the rally this morning
Experts
Scopo’s Health Powerplays: Show me the (grant) money
News
Trading Places: Cybersecurity stocks are in hot demand by fund managers
Health & Biotech
Check up: A good fortnight to be a small cap health investor
Experts
Scopo’s health powerplays: quick vaccine hits and cheap buys
Health & Biotech
Pharmaxis forges ahead with phase 2 cancer drug trial in spite of COVID-19
Health & Biotech
Dr Boreham’s Crucible: Why CSL is the poster child for most junior drug developers
News
